Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Surgery (49)
- Anatomy (43)
- Cardiovascular System (43)
- Diseases (8)
- Cardiovascular Diseases (7)
-
- Critical Care (5)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (3)
- Other Pharmacy and Pharmaceutical Sciences (3)
- Pharmacy and Pharmaceutical Sciences (3)
- Infectious Disease (2)
- Medical Sciences (2)
- Bacterial Infections and Mycoses (1)
- Behavioral Economics (1)
- Biomedical Devices and Instrumentation (1)
- Biomedical Engineering and Bioengineering (1)
- Biotechnology (1)
- Circulatory and Respiratory Physiology (1)
- Dietetics and Clinical Nutrition (1)
- Economics (1)
- Engineering (1)
- Equipment and Supplies (1)
- Health Information Technology (1)
- Immune System Diseases (1)
- Investigative Techniques (1)
- Life Sciences (1)
- Medical Biotechnology (1)
- Nephrology (1)
- Keyword
-
- Heart failure (39)
- Left ventricular assist device (28)
- Ventricular assist device (21)
- LVAD (16)
- Heart transplantation (7)
-
- Left Ventricular Assist Device (7)
- Mechanical circulatory support (7)
- Cardiology (5)
- Complications (5)
- Pump thrombosis (5)
- Cardiogenic shock (4)
- Extracorporeal membrane oxygenation (4)
- Gastrointestinal bleeding (4)
- Hemodynamics (4)
- Impella (4)
- Thrombosis (4)
- Bleeding (3)
- COVID-19 (3)
- CardioMEMS (3)
- Heart Failure (3)
- Inotropes (3)
- ACLS (2)
- Advanced heart failure (2)
- Anticoagulation (2)
- Aortic insufficiency (2)
- CPR (2)
- Cardiac arrest (2)
- Cardiac transplantation (2)
- Driveline (2)
- Echocardiography (2)
Articles 91 - 120 of 120
Full-Text Articles in Cardiology
Va-Ecmo In Cardiogenic Shock In Adults: Indications And Outcomes, Maya Guglin, Andrew Burchett
Va-Ecmo In Cardiogenic Shock In Adults: Indications And Outcomes, Maya Guglin, Andrew Burchett
The VAD Journal
Background
Use of veno-arterial extra-corporeal membrane oxygenation (VA-ECMO) has become increasingly common as a means of providing hemodynamic support for patients in cardiogenic shock. Data regarding the efficacy of VA-ECMO are provided almost exclusively by single-center, retrospective analyses. These retrospective analyses vary significantly with regards to documentation of the underlying pathophysiologic process resulting in cardiogenic shock.
Methods
Relevant published studies were identified by using a comprehensive search of English-language MEDLINE from 1966 to November 2015. Relevant references found cited in these studies were also analyzed. These studies were analyzed with regard to the indications the authors used for initiation of …
Bleeding And Thromboembolic Events In Patients With Heartmate Ii Mechanical Circulatory Support, Salman Allana, Carrie Chapman, Nancy Sweitzer, Maryl Johnson, Takushi Kohmoto, Margaret Murray, David Murray, Zhanhai Li, Peter S. Rahko
Bleeding And Thromboembolic Events In Patients With Heartmate Ii Mechanical Circulatory Support, Salman Allana, Carrie Chapman, Nancy Sweitzer, Maryl Johnson, Takushi Kohmoto, Margaret Murray, David Murray, Zhanhai Li, Peter S. Rahko
The VAD Journal
Background: Bleeding and thromboembolic events (TE) are common complications following HeartMate II (HMII) implantation. The aim of the study was to review our experience related to bleeding and TE events in patients with a HMII and identify factors associated with increased risk of these events.
Methods: We retrospectively reviewed 70 consecutive patients who received a HMII between May 2006 and December 2011. The patients were followed for 12 months or until cardiac transplantation, device explantation or death. Major bleeding was defined by INTERMACS criteria with intracranial bleeding events added.
Results: There were 48 bleeding events in 28 (40%) patients with …
Lung Edema On Va Ecmo, Christof Schmid Md
Temporary And Durable Mechanical Circulatory Support For Single Ventricular Failure In An Adult, Joshua L. Hermsen, Jason W. Smith, Jay D. Pal, Agustin Rubio, S. Carolina Masri, Nahush A. Mokadam, Richard K. Cheng, Claudius Mahr
Temporary And Durable Mechanical Circulatory Support For Single Ventricular Failure In An Adult, Joshua L. Hermsen, Jason W. Smith, Jay D. Pal, Agustin Rubio, S. Carolina Masri, Nahush A. Mokadam, Richard K. Cheng, Claudius Mahr
The VAD Journal
Patients palliated with Fontan circulation requiring mechanical circulatory support pose anatomic and physiologic challenges. We treated a Fontan patient with acute ventricular failure with sequential temporary and durable support devices. Aspects of treatment with each device required modification based on the patient’s anatomy and physiology.
Decrease In Driveline Infections With Change In Driveline Management Protocol, Saima Aslam, Jennifer Dan, Amanda Topik, Michael Belyk, Francesca Torriani, Randy Taplitz, Jorge Silva-Enciso, Denise Barnard, Barry Greenberg, Jack Copeland, Victor Pretorius, Eric Adler
Decrease In Driveline Infections With Change In Driveline Management Protocol, Saima Aslam, Jennifer Dan, Amanda Topik, Michael Belyk, Francesca Torriani, Randy Taplitz, Jorge Silva-Enciso, Denise Barnard, Barry Greenberg, Jack Copeland, Victor Pretorius, Eric Adler
The VAD Journal
Background: Driveline infections (DLI) are a significant cause of morbidity and mortality in ventricular assist device (VAD) recipients. We compared driveline infection (DLI) rate after an institutional change in driveline management protocol.
Methods: We retrospectively reviewed records of left VAD recipients at our institution, based on driveline management. Group 1: daily driveline dressing change consisting of chlorhexidine cleansing, sterile 4x4 gauze, and use of an abdominal binder. Group 2: Dressing change every 3 days consisting of chlorhexidine cleansing, non-sterile silver-impregnated foam with overlying clear dressing, and use of a driveline anchor. Follow-up was censored at first DLI, device removal, transplant …
Pulmonary Congestion (White Lungs) On Va Ecmo, Maya Guglin, Andrew Burchett, Thomas Tribble, Richard Charnigo
Pulmonary Congestion (White Lungs) On Va Ecmo, Maya Guglin, Andrew Burchett, Thomas Tribble, Richard Charnigo
The VAD Journal
Veno-arterial extracorporeal membrane oxygenation therapy (VA ECMO) is used for short-term circulatory support in the setting of cardiogenic shock or cardiac arrest. While VA-ECMO improves hemodynamics and gas exchange, it may result in left ventricular distention and pulmonary congestion.
Methods
The records of all patients supported with VA ECMO for at least three consecutive days at our institution from 2012-2014 were retrospectively analyzed. All chest radiographs taken during VA ECMO support were graded on a scale of 1 to 4. A score of 1 was used when no pulmonary congestion was present. A score of 2 was used for congestion …
Development And Pilot-Testing Of A Patient Decision Aid For Left Ventricular Assist Device Placement, Kristin Kostick, Estevan D. Delgado, Lidija A. Wilhelms, Courtenay R. Bruce, Jerry D. Estep, Matthias Loebe, Charles Minard, Jennifer S. Blumenthal-Barby
Development And Pilot-Testing Of A Patient Decision Aid For Left Ventricular Assist Device Placement, Kristin Kostick, Estevan D. Delgado, Lidija A. Wilhelms, Courtenay R. Bruce, Jerry D. Estep, Matthias Loebe, Charles Minard, Jennifer S. Blumenthal-Barby
The VAD Journal
Objectives: This paper describes the development methodology and pilot-testing of a decision aid for Left Ventricular Assist Device (LVAD) placement, combining traditional needs-assessment with a novel user-centered approach.
Background: Studies indicate suboptimal patient understanding of the capabilities, lifestyle implications, and risks of LVAD therapy.
Methods and Results: We developed the decision aid in line with the Ottawa Decision Support Framework (ODSF) and the International Patient Decision Aids Standards (IPDAS) for ensuring quality, patient-centered content. Structured interviews were conducted with patients, caregivers, candidates for LVAD treatment, and expert clinicians (n=71) to generate content based on patient values and …
What Did We Learn About Vads In 2015?, Maya Guglin
What Did We Learn About Vads In 2015?, Maya Guglin
The VAD Journal
No abstract provided.
Low-Dose Vitamin K Can Improve Warfarin Control In Patients On Lvad Support, Daizo Tanaka, Venessa L. Kotch, Cheryl Abbas, Gordon Reeves, John Wc Entwistle Iii
Low-Dose Vitamin K Can Improve Warfarin Control In Patients On Lvad Support, Daizo Tanaka, Venessa L. Kotch, Cheryl Abbas, Gordon Reeves, John Wc Entwistle Iii
The VAD Journal
Background
Anticoagulation with oral vitamin K antagonists (VKA) is very important in patients supported on a left ventricular assist device (LVAD) to prevent thromboembolic complications. Some patients tolerate VKAs poorly and have an unstable INR as a result. It is reported that low-dose vitamin K can improve INR control in patients with an unstable INR in other clinical settings. We evaluated its safety and effectiveness in patients on LVAD support.
Methods
The records of all patients supported on an implantable LVAD between January, 2013 and March, 2014 were reviewed retrospectively to identify those who had received low-dose vitamin K while …
Damaging Cardiac And Cancer Genetic Variants In The Lvad Population, Brian D. Lowes Md, Phd, Eric T. Rome, Kajari Dhar, Jeff Kittrell, James D. Eudy, John Y. Um, Alexandra Moulton, J. Zao, Ronald Redder, Michael J. Moulton, Daniel R. Anderson, Eugenia Raichlin
Damaging Cardiac And Cancer Genetic Variants In The Lvad Population, Brian D. Lowes Md, Phd, Eric T. Rome, Kajari Dhar, Jeff Kittrell, James D. Eudy, John Y. Um, Alexandra Moulton, J. Zao, Ronald Redder, Michael J. Moulton, Daniel R. Anderson, Eugenia Raichlin
The VAD Journal
Background: Next generation sequencing technology, coupled with population genetic databases, have made broad genetic evaluation relatively inexpensive and widely available. Our objective was to assess the prevalence of potentially damaging cancer and cardiac gene variants in advanced non-ischemic cardiomyopathy patients.
Methods: Explanted human heart tissue procured at LVAD placement was obtained from the University of Nebraska Medical Center Heart Tissue Bank. Genomic DNA was isolated from tissues and amplified by PCR using targeted ampliseq primer pools from an inherited disease panel. Individual libraries were amplified by emulsion PCR on Ion Sphere particles and sequencing was performed on a …
Early Manifestations Of Atrial Tamponade In A Patient Implanted With Syncardia Total Artificial Heart., Manoj Thangam, Bindu Akkanti, Sriram Nathan, Daniel Ocazionez-Trujillo, Indranee Rajapreyar, Manish K. Patel, Jayesh Patel, Pranav Loyolka, Biswajit Kar, Igor Gregoric
Early Manifestations Of Atrial Tamponade In A Patient Implanted With Syncardia Total Artificial Heart., Manoj Thangam, Bindu Akkanti, Sriram Nathan, Daniel Ocazionez-Trujillo, Indranee Rajapreyar, Manish K. Patel, Jayesh Patel, Pranav Loyolka, Biswajit Kar, Igor Gregoric
The VAD Journal
Implantation rates of the SynCardia Total Artificial Heart (TAH) system is growing owing to the increasing incidence of biventricular heart failure and the limited number of transplantable hearts. Among the complications associated with the device, atrial tamponade is an emergent condition that requires immediate attention. Atrial tamponade occurs when increasing pericardial hemorrhage leads to atrial compression that produces tamponade physiology and compromises cardiac output. Unfortunately to our knowledge, information concerning the early manifestations of tamponade in TAH patients is extremely scarce. Previous reports have focused on decreased cardiac output as an indicator of tamponade. However, other presentations including pulmonary decompensation …
Massive Pulmonary Embolism With Hemodynamic Compromise Successfully Treated With Veno-Arterial Extracorporeal Membrane Oxygenation, B. Akkanti, S. Nathan, E. N. Centeno, K. Akasapu, P. Doshi, R. Hussain, F. Raissi, A. Nascimbene, R. Srinivasan, I. Rajapreyar, M. Patel, J. Patel, M. Akay, P. Loyalka, B. Kar, I. Gregoric
Massive Pulmonary Embolism With Hemodynamic Compromise Successfully Treated With Veno-Arterial Extracorporeal Membrane Oxygenation, B. Akkanti, S. Nathan, E. N. Centeno, K. Akasapu, P. Doshi, R. Hussain, F. Raissi, A. Nascimbene, R. Srinivasan, I. Rajapreyar, M. Patel, J. Patel, M. Akay, P. Loyalka, B. Kar, I. Gregoric
The VAD Journal
Introduction: Cardiogenic shock that results from pulmonary embolus has a high mortality rate. Systemic thrombolysis is frequently used in submassive and massive pulmonary embolus and has been shown to restore circulation. However, in the event of impending or ongoing cardiac arrest, systemic thrombolysis or anticoagulation alone has not been always shown to be effective. Case reports have previously established that extracorporeal membrane oxygenation can effectively be used as an effective rescue strategy in cases of cardiac arrest as a result from massive pulmonary embolus. We report six cases of massive pulmonary embolism (PE), in which veno-arterial extracorporeal membrane oxygenation (VA …
Systemic Candidiasis And Cytomegalovirus Infection In The Setting Of Artificial Cardiac Device Deployment., Manoj Thangam, Bindu Akkanti, Maan Malahafio, Sriram Nathan, Indranee Rajapreyar, Pranav Loyalka, Biswajit Kar, Igor Gregoric
Systemic Candidiasis And Cytomegalovirus Infection In The Setting Of Artificial Cardiac Device Deployment., Manoj Thangam, Bindu Akkanti, Maan Malahafio, Sriram Nathan, Indranee Rajapreyar, Pranav Loyalka, Biswajit Kar, Igor Gregoric
The VAD Journal
Heart failure is a serious cause of morbidity and mortality worldwide. The advent of implantable cardiac assist devices has generated a new arsenal for treating severe heart failure. However, the potential ramifications of ventricular assist device (VAD) usage are not fully understood. Immune modulation resulting from VAD implantation is an area of growing research. Although we do not fully understand the mechanisms contributing to host immune alteration, changes in cytokine concentrations, deceased lymphocyte activity, and the local effects of device materials have been shown to down regulate immune function. 7,8 Infection is a serious complication that affects prognosis in this …
Commentary On "Systemic Candidiasis And Cytomegalovirus Infection In The Setting Of Artificial Cardiac Device Deployment", Moises A. Huaman
Commentary On "Systemic Candidiasis And Cytomegalovirus Infection In The Setting Of Artificial Cardiac Device Deployment", Moises A. Huaman
The VAD Journal
No abstract provided.
Use Of Social Media As A Virtual Community And Support Group By Left Ventricular Assist Device (Lvad) Patients, Bryan Boling, Amanda Hart, Chizimuzo T.C. Okoli, Tamra Halcomb, Peggy El-Mallakh
Use Of Social Media As A Virtual Community And Support Group By Left Ventricular Assist Device (Lvad) Patients, Bryan Boling, Amanda Hart, Chizimuzo T.C. Okoli, Tamra Halcomb, Peggy El-Mallakh
The VAD Journal
Abstract
Background
Left ventricular assist device (LVAD) patients may benefit from participating in a social support group; however, several factors may limit the availability of these communities. Alternatively, online social support communities may be more accessible for LVAD patients. No studies have examined patterns and reasons for health-related social media use among people with LVADs
Methods
An online survey of patients actively participating in LVAD social media groups was conducted using both multiple choice and open-ended questions.
Results
Thirty-nine participants (65% male) completed the survey. Participants’ reasons for weekly engagement in online communities were to seek (69.2%) and offer (66.7%) …
Chronic Ldh Elevation After Left Ventricular Assist Device Implantation, Hesham R. Omar, Navin Rajagopalan, Maya Guglin
Chronic Ldh Elevation After Left Ventricular Assist Device Implantation, Hesham R. Omar, Navin Rajagopalan, Maya Guglin
The VAD Journal
A 61-year-old woman who underwent HeartMate II left ventricular assist device placement for non-ischemic cardiomyopathy developed elevated lactate dehydrogenase within two weeks after implantation. After eight months of observation and several hospital admissions during which there was no evidence of pump thrombosis, she presented with clinically manifest hemolysis. During pump exchange there was notable pannus formation on the inflow cannula of the left ventricular assist device. The pannus around the inflow likely existed for several months, limiting the flow and creating a low-grade hemolysis and this low flow state stimulated thrombus formation triggering gross hemolysis. Thoratec analysis of the pump …
Chronic Hemodialysis In A Patient With Left Ventricular Assist Device., Amr Idris, Georges Lolay, Ana L. Castellanos, Navin Rajagopalan, Maya Guglin
Chronic Hemodialysis In A Patient With Left Ventricular Assist Device., Amr Idris, Georges Lolay, Ana L. Castellanos, Navin Rajagopalan, Maya Guglin
The VAD Journal
Renal dysfunction in the setting of heart failure is a common medical problem. This dysfunction can range from reversible ischemic changes to renal failure requiring renal replacement therapy. Patients who are candidates for mechanical circulatory support with left ventricular assistant device (LVAD) pose unique challenge with respect to receiving dialysis. We present a 47 year old patient who required renal replacement therapy peri-implantation of LVAD for management of acute on chronic kidney disease, and was discharged for chronic hemodialysis in an outpatient setting. In this report we highlight the challenges of managing volume overload in patients with impaired renal function …
Veraflo Negative Pressure Wound Therapy With Household Bleach For Refractory Driveline Infection In A Patient With Left Ventricular Assist Device., Amr Idris, Amanda Hart, Sarah Branam, Maya Guglin
Veraflo Negative Pressure Wound Therapy With Household Bleach For Refractory Driveline Infection In A Patient With Left Ventricular Assist Device., Amr Idris, Amanda Hart, Sarah Branam, Maya Guglin
The VAD Journal
Driveline infections and sepsis are amongst the most common causes of morbidity and mortality in a patient with a left ventricular assist device. In this case, we present a patient with a multi drug resistant pseudomonas aeruginosa driveline exit site infection. Initially, it was treated with dual antibiotics, followed by surgical debridement utilizing Dakin’s solution irrigation and standard negative pressure wound therapy. Wound healing was minimal determined by poor granulation appearance, unchanged size from surgical debridement, purulent drainage, and the wound base remained colonized with multi drug resistant pseudomonas aeruginosa. A novel treatment of VeraFlo negative pressure wound therapy in …
Inotropes Are Linked To Increased Mortality In Heart Failure, M. Chadi Alraies, Bill Tran, Sirtaz Adatya
Inotropes Are Linked To Increased Mortality In Heart Failure, M. Chadi Alraies, Bill Tran, Sirtaz Adatya
The VAD Journal
No abstract provided.
Inotropes Are Not Linked To Increased Mortality In Heart Failure, Maya Guglin
Inotropes Are Not Linked To Increased Mortality In Heart Failure, Maya Guglin
The VAD Journal
How to use inotropes is one of the most controversial topics in the management of heart failure. While most clinicians use these drugs, and recognize the state of inotrope dependency, current guidelines recommend them onlu as a bridge or palliation. Thus, inotropes are considered either neutral or detrimental in terms of outcomes. Meanwhile, properly designed randomized clinical trials testing the outcomes on inotropes, have never been performed and it is unlikely that they will ever be attempted. These trials would require randomizing patients with advanced heart failure, low output syndrome, and impaired end-organ perfusion into groups that received or not …
St-Segment Elevation Myocardial Infarction In Patient With Left Ventricular Assist Device, Navin Rajagopalan, Ryan E. Wilson
St-Segment Elevation Myocardial Infarction In Patient With Left Ventricular Assist Device, Navin Rajagopalan, Ryan E. Wilson
The VAD Journal
Acute myocardial infarction is a rare event in a patient with a left ventricular assist device (LVAD). We present a case of ST-segment elevation myocardial infarction in a LVAD patient.
What Did We Learn About Vads In 2014?, Maya Guglin
What Did We Learn About Vads In 2014?, Maya Guglin
The VAD Journal
No abstract provided.
Surgical Considerations Of Lvad Implantation In Patients With Prosthetic Valves, Igor D. Gregoric
Surgical Considerations Of Lvad Implantation In Patients With Prosthetic Valves, Igor D. Gregoric
The VAD Journal
No abstract provided.
Old Dog, New Tricks - Usefulness Of The Ecg In Monitoring Acute Rejection Post Cardiac Transplantation, Paul Anaya, Samy-Claude Elayi
Old Dog, New Tricks - Usefulness Of The Ecg In Monitoring Acute Rejection Post Cardiac Transplantation, Paul Anaya, Samy-Claude Elayi
The VAD Journal
Electrocardiographic abnormalities have been described in the setting of acute rejection following orthotopic cardiac transplantation. The following is a brief commentary related to an interesting case report by Goldraich et al. which was recently published in the VAD Journal.
Successful Left Ventricular Assist Device Support In Patient With Bjork-Shiley Mitral Valve Replacement, Navin Rajagopalan, David C. Booth
Successful Left Ventricular Assist Device Support In Patient With Bjork-Shiley Mitral Valve Replacement, Navin Rajagopalan, David C. Booth
The VAD Journal
There is limited clinical experience with left ventricular assist device therapy in patients with prosthetic mitral valves. We present a case of successful left ventricular assist device support in a patient with previous mechanical mitral valve replacement.
Old School Still Has Merit: Ecg As A Marker Of Cardiac Recovery At Weaning From Mechanical Circulatory Support, Livia Adams Goldraich, Vivek Rao, Fillio Billia, Heather Joan Ross
Old School Still Has Merit: Ecg As A Marker Of Cardiac Recovery At Weaning From Mechanical Circulatory Support, Livia Adams Goldraich, Vivek Rao, Fillio Billia, Heather Joan Ross
The VAD Journal
In a case of acute cardiac allograft failure requiring temporary mechanical circulatory support (MCS), serial electrocardiograms (ECG) denoted the degree of myocardial inflammation and damage caused by severe rejection and subsequent recovery. This case highlights the relevance of the ECG during temporary MCS and suggests that resolution of acute electrocardiographic abnormalities might be a marker of myocardial recovery to help guide appropriate timing for weaning from MCS in the setting of acute graft failure.
Heartmate Ii Post-Marketing Clinical Studies To Further Establish And Expand Lvad Therapy, Faouzi Kallel
Heartmate Ii Post-Marketing Clinical Studies To Further Establish And Expand Lvad Therapy, Faouzi Kallel
The VAD Journal
No abstract provided.
Left Ventricular Assist Device As Destination Therapy, Maya Guglin, Leslie W. Miller
Left Ventricular Assist Device As Destination Therapy, Maya Guglin, Leslie W. Miller
The VAD Journal
Mechanical circulatory support is the most rapidly evolving strategy in heart failure management. The growing number of patients who need better results than medical therapy can offer, the limited pool of donors for cardiac transplantation, and several technological breakthroughs have all made the option of implanting a left ventricular assist device (LVAD) as destination therapy more important.
In this review, we outline the indications and decision making process of considering a patient for a destination therapy LVAD, as well as outcomes, complications, and issues related to management of patients on currently approved devices. The future direction of the field will …
The Bubbling Aorta, Hesham R. Omar, Maya Guglin
The Bubbling Aorta, Hesham R. Omar, Maya Guglin
The VAD Journal
We are presenting the image of the bubbles in the descending aorta in a patient on VA ECMO.
Dear Colleagues, Readers And Authors, Maya Guglin
Dear Colleagues, Readers And Authors, Maya Guglin
The VAD Journal
No abstract provided.